Effectiveness of Aprepitant in Addition to Ondansetron in the Prevention of Nausea and Vomiting Caused by Upper Abdominal Radiotherapy (AVERT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00970905
Recruitment Status : Completed
First Posted : September 3, 2009
Last Update Posted : December 5, 2017
Mayo Clinic
Wake Forest University Health Sciences
Norris Cotton Cancer Center
University of Massachusetts, Worcester
Information provided by (Responsible Party):
Steven Ades, University of Vermont

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : July 1, 2016
  Actual Study Completion Date : August 1, 2016